Evidence map›Paper›PMID 21600237›Full record

ReviewMechanisms of ageing and development2011

Cdk5: mediator of neuronal development, death and the response to DNA damage.

Jinqiu Zhu, Wenming Li, Zixu Mao

Open access · greenAbstract readReview
In one paragraph

Review in Mechanisms of ageing and development, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. How Can Insulin Resistance Cause Alzheimer's Disease?International journal of molecular sciences · 2023
    Review
  7. Suppressing Cdk5 Activity by Luteolin Inhibits MPPMolecules (Basel, Switzerland) · 2021
    Article
  8. Review
  9. An ImprovedFrontiers in neuroscience · 2019
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jinqiu ZhuDepartment of Pharmacology, Emory University School of Medicine, Whitehead Bldg., Rm505L 615 Michael St., Atlanta, GA 30322, USA.
Wenming Li
Zixu Mao
Emory University · US

Funding

PROJECT 3: METABOLOMIC BIOMARKERS OF PARKINSON'S DISEASEP01ES016731 · NIEHS · EMORY UNIVERSITY · PI MILLER, GARY W · 2008 to 2012
$6.7M
Phosphorylation-mediated inhibition of MEF2 in neuronR01AG023695 · NIA · RHODE ISLAND HOSPITAL · PI MAO, ZIXU · 2004 to 2017
$3.1M
Nuclear integration of environmental toxic signals relevant to PDR01ES015317 · NIEHS · EMORY UNIVERSITY · PI MAO, ZIXU · 2007 to 2011
$1.7M
Nuclear mechanisms of Cdk5-mediated neuronal apoptosisR01NS048254 · NINDS · RHODE ISLAND HOSPITAL · PI MAO, ZIXU · 2004 to 2008
$1.4M
NIA NIH HHS AG023695NIA NIH HHS R01 AG023695NIEHS NIH HHS ES015317NIEHS NIH HHS ES016731-0002NIEHS NIH HHS R01 ES015317NINDS NIH HHS NS048254NINDS NIH HHS R01 NS048254
6 · The paper itself

Abstract

In the central nervous system, cyclin-dependent kinase 5 (Cdk5), an unusual member of the Cdk family, is implicated in the regulation of various physiological processes ranging from neuronal survival, migration and differentiation, to synaptogenesis, synaptic plasticity and neurotransmission. Dysregulation of this kinase has been demonstrated to play a critical role in the pathogenic process of neurodegenerative disorders. DNA damage is emerging as an important pathological component in various neurodegenerative conditions. In this review, we discuss the recent progress regarding the regulation and roles of Cdk5 under physiological conditions, and its dysregulation under pathological conditions, especially in neuronal death mediated by DNA damage.

Indexed as

DNA DamageAnimalsCell DeathCell MovementCell SurvivalCyclin-Dependent Kinase 5HumansNeurodegenerative DiseasesNeuronal PlasticityNeuronsSynaptic TransmissionCDK5 protein, humanCyclin-Dependent Kinase 5

Identifiers

PMID21600237
PMCPMC3179526
OpenAlexW1966142302

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.